Maryland’s Opioid Restitution Fund (ORF) was established in 2019 to receive all monies awarded to the State of Maryland through prescription opioid-related legal action. In 2022, Maryland established the ORF Advisory Council to provide recommendations regarding the use of those funds. For all inquiries, email [email protected].
Resources
- NEW: Opioid Restitution Fund Primer
- State-Subdivision Agreement (January 2022 – Janssen)
- State-Subdivision Agreement (April 2023 – Teva, Allergan, & Walmart)
- Janssen Settlement – Exhibit E (allowable uses)
- Statutory Mandate (updated in 2024 with Senate Bill 751)
- 2025 MOOR Recommendations for Local Spending
- Fiscal Year 2025 State Discretionary Abatement Fund Awards Summary
- Settlement Funds by Subdivision Spreadsheet
(Use this link to download the file. Once downloaded, click “enable editing.”) - Bulletin: Municipality TAG Reversion to County
- Opioid Restitution Fund Policy Bulletin: Allowable Spending
- Opioid Restitution Fund Policy Bulletin: Expenditure Reporting Requirements
Opioid Restitution Fund Advisory Council
Maryland’s Opioid Restitution Fund (ORF) Advisory Council was established in 2022 to provide recommendations regarding the use of prescription opioid-related legal settlement funds. As specified by state statute (Maryland Health General Article §7.5–903), the council consists of 12 members who serve for two years.
Click here to learn more: https://stopoverdose.maryland.gov/orf-advisorycouncil/
Prescription Opioid Settlement Information
As of the 2024 fiscal year (July 1, 2023 – June 30, 2024), Maryland has received distributions through seven prescription opioid-related legal settlements. Visit the Settlement Overview page for more information: https://stopoverdose.maryland.gov/orf-settlement-overview/
Stay in Contact!
To receive notifications regarding Maryland’s overdose crisis response efforts, please complete the following form to be added to our mailing list.
1-888-373-7888
233733